Zurich Cantonal Bank
LEGN icon

Zurich Cantonal Bank’s Legend Biotech LEGN Stock Holding History

Zurich Cantonal Bank’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.81M Buy
62,746
+47,551
+313% +$1.28M ﹤0.01% 1193
2026
Q1 		$275K Sell
15,195
-232
-2% -$4.42K ﹤0.01% 2136
2025
Q4 		$335K Sell
15,427
-130,220
-89% -$3.73M ﹤0.01% 1993
2025
Q3 		$4.75M Buy
145,647
+51,523
+55% +$1.9M 0.01% 625
2025
Q2 		$3.34M Buy
94,124
+53,218
+130% +$1.72M 0.01% 690
2025
Q1 		$1.39M Sell
40,906
-7
-0% -$251 ﹤0.01% 989
2024
Q4 		$1.33M Sell
40,913
-9,355
-19% -$388K ﹤0.01% 1059
2024
Q3 		$2.45M Buy
50,268
+19,198
+62% +$1.02M 0.01% 738
2024
Q2 		$1.38M Buy
31,070
+6,366
+26% +$294K ﹤0.01% 905
2024
Q1 		$1.39M Buy
24,704
+6,665
+37% +$402K ﹤0.01% 900
2023
Q4 		$1.09M Buy
18,039
+5,084
+39% +$322K ﹤0.01% 1019
2023
Q3 		$870K Sell
12,955
-4,156
-24% -$289K ﹤0.01% 1048
2023
Q2 		$1.18M Sell
17,111
-26
-0.2% -$1.7K 0.01% 869
2023
Q1 		$826K Buy
17,137
+5,080
+42% +$248K ﹤0.01% 996
2022
Q4 		$602K Sell
12,057
-10
-0.1% -$484 ﹤0.01% 1143
2022
Q3 		$492K Hold
12,067
– – ﹤0.01% 1208
2022
Q2 		$664K Sell
12,067
-10,261
-46% -$433K ﹤0.01% 1043
2022
Q1 		$811K Buy
22,328
+6,957
+45% +$275K ﹤0.01% 1034
2021
Q4 		$716K Buy
15,371
+10,641
+225% +$540K ﹤0.01% 1201
2021
Q3 		$239K Buy
+4,730
New +$197K ﹤0.01% 1801

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Zurich Cantonal Bank's LEGN Position: Q2 2026 in Review

Zurich Cantonal Bank increased its Legend Biotech (LEGN) stake by 313% in Q2 2026, buying an estimated $1.28M and bringing the position to 62,746 shares worth $1.81M. The position accounts for ﹤0.01% of the portfolio, ranked #1193.

Zurich Cantonal Bank first reported a position in LEGN in Q3 2021 and has held it in 20 quarters since. The position peaked at $4.75M in Q3 2025. 218 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Zurich Cantonal Bank held 62,746 shares of Legend Biotech worth $1.81M as of Q2 2026.
  • Zurich Cantonal Bank bought 47,551 Legend Biotech shares in Q2 2026, an estimated $1.28M.
  • Legend Biotech made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #1193 holding.
  • Zurich Cantonal Bank first reported a position in Legend Biotech in Q3 2021 and has held it in 20 quarters since.
  • Zurich Cantonal Bank's Legend Biotech position peaked at $4.75M in Q3 2025.
  • 218 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.